Skip to main content
. 2022 Mar 17;23(5):158. doi: 10.3892/ol.2022.13278

Figure 1.

Figure 1.

Higher expression of IL-33 in cancerous tissues is associated with improved overall and progression-free survival. Expressions of (A) IL-33 and (B) ST2 in the para-carcinoma and carcinoma tissues from patients with ovarian cancer measured using reverse transcription-quantitative PCR (n=10). Survival analysis of the association between the expression of IL-33 and (C) OS and (D) PFS (n=156), and association between the expression of ST2 and (E) OS and (F) PFS (n=156). (G) Co-localization of IL-33 with α-SMA but without PAX8 and CD45 detected by immunofluorescence staining. ***P<0.001. OS, overall survival; PFS, progression-free survival; ST2, interleukin-1 receptor-like 1.